---
layout: post
title: "Why do omic foundation models keep failing?"
date: 2025-02-02
tags: [Deep Learning, Genomics]
excerpt: "A structured look at why foundation models still struggle on omic tasks like gene perturbation prediction, and the directions that might fix it."
---

Two recent reads got me thinking about this question: *Genomic Foundationless Models: Pretraining Does Not Promise Performance*, and the observation that deep-learning predictions of gene perturbation effects do not yet outperform simple linear methods.

Foundation models struggle with omic tasks such as gene perturbation prediction and genome representation because of a combination of intrinsic biological complexity and methodological limitations. Here is a structured breakdown of the key reasons.

## Data challenges

- **Sparsity and high dimensionality.** Omic data (gene expression, epigenetics) often has thousands of features but limited samples, which leads to overfitting.
- **Noise and variability.** Technical artifacts such as batch effects, together with biological variability, reduce signal-to-noise ratios and complicate generalization.
- **Privacy and accessibility.** Sensitive genomic data restricts large-scale aggregation, limiting the diversity and volume of training data.

## Biological complexity

- **Non-linear interactions.** Gene regulation involves intricate feedback loops, epistasis, and context-dependent interactions that are hard to model.
- **Multi-modality and dynamics.** Integrating diverse data types (DNA, RNA, proteins) and capturing temporal or spatial dynamics such as cell-state changes exceeds current model capabilities.

## Architectural limitations

- **Sequence length.** Genomes are orders of magnitude longer than text sequences, which challenges Transformer-based models with limited context windows.
- **Ignoring 3D structure.** Models often overlook chromatin folding and epigenetic spatial interactions that are critical for gene regulation.

## Learning paradigms

- **Ineffective self-supervision.** Tasks like masked nucleotide prediction may not capture higher-order biological functions such as gene ontology or pathway interactions.
- **Task specificity.** Broad pretraining can miss the nuances required for specialized tasks such as predicting CRISPR knockout effects.

## Evaluation and interpretability

- **Misaligned metrics.** Performance metrics such as accuracy may not correlate with biological relevance or clinical utility.
- **Black-box nature.** Biologists require mechanistic insight, but foundation models often lack interpretability.

## Practical barriers

- **Validation costs.** Experimental validation is slow and expensive, which hinders iterative model refinement.
- **Regulatory hurdles.** Compliance with data privacy laws such as GDPR complicates data sharing and reuse.

## Emerging solutions

- **Improved architectures.** Hierarchical or sparse Transformers to handle long sequences, and graph neural networks for interaction networks.
- **Better pretraining tasks.** Incorporating gene ontology, pathway data, or synthetic data to enhance biological relevance.
- **Multi-modal integration.** Combining omics with imaging, clinical data, or literature to enrich context.
- **Active learning.** Prioritizing high-impact experiments to reduce validation costs.
